Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Exploratory Clinical Study of HRS-4642 Combined With Adebelimab in the Treatment of Advanced Pancreatic Cancer [Phase 1, Phase 2]
Exploratory Phase 1/2 trial evaluating HRS-4642 in combination with Adebelimab for advanced pancreatic cancer; study status: recruiting.
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update describes an ongoing Phase 1/2 study of CAR-T cells targeting the carcinoembryonic antigen (CEA) for CEA-positive…
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial from Fudan University is evaluating adebrelimab in combination with NALIRIFOX for locally advanced pancreatic cance…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice [NA]
This clinical trial registry entry describes a new preoperative drainage strategy for resectable pancreatic head cancer with severe obstruct…
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Clinical Study Evaluating the Effect of Losartan [NA]
A clinical trial is evaluating losartan for pancreatic cancer and is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study [Phase 2]
Open-phase 2 multicenter trial evaluating Milaberon in advanced solid tumors across multiple indications, currently recruiting.
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety [Phase 2]
A Phase 2 trial evaluating Adebelimab in combination with irinotecan liposome, oxaliplatin, fluorouracil, and calcium folinate as first-line…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Surufatinib Combined With Serplulimab and Standard Chemotherapy as First-line Treatment in Advanced Solid Tumors With Neuroendocrine Differentiation [Phase 2]
Phase 2 study evaluating first-line surufatinib plus serplulimab with standard chemotherapy for advanced solid tumors with neuroendocrine di…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: The LINFU® U.S. Registry for the in the General Population Without Risk Factors
A clinical trial registry update from Adenocyte, LLC about the LINFU U.S. Registry; the study (NCT06276803) is not yet recruiting and involv…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Research of the Application of Artificial Intelligence Model "PANDA" [NA]
An update on a clinical trial researching an artificial intelligence model called PANDA for pancreatic cancer, with the study currently not …
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
A multicenter study in China is investigating features of the gut microbiota in patients with several chronic diseases and is currently recr…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
The LEARN trial by the University of Sydney is evaluating a new AI-based radiotherapy environment and is currently recruiting across several…
-
CLINICAL_TRIALS research · 2024-07-25Clinical Trial Update: Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2 [Phase 1, Phase 2]
Clinical trial update on systemic therapy and chemoradiation for locally advanced, non-metastatic pancreatic cancer (Phase 1/Phase 2) conduc…
-
CLINICAL_TRIALS research · 2024-07-24Clinical Trial Update: Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors [Phase 1]
This is a Phase 1 clinical trial update for UCMYM802 Injection in mesothelin-positive advanced malignant solid tumors, listing several cance…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer [Phase 1, Phase 2]
This clinical trial entry describes a Phase 1/Phase 2 study evaluating a three-drug first-line regimen (irinotecan liposome, albumin-bound p…
-
CLINICAL_TRIALS research · 2024-07-17Clinical Trial Update: QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. [Phase 1]
Phase 1 trial update for YE-NEO-001, NantBioScience's personalized neoepitope yeast vaccine, evaluating adjuvant immunotherapy to elicit T-c…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures
A Zhejiang University-backed study aims to enable early diagnosis of resectable pancreatic cancer by deciphering multi-modal immunological s…
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Effectiveness of the Transversus Abdominis Plane Block Associated With Opioid Spinal Anesthesia on Analgesia After Cephalic Duodenopancreatectomy
A clinical trial is investigating the effectiveness of a transversus abdominis plane block with opioid spinal anesthesia to improve analgesi…
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer [NA]
Clinical trial update describing first-line treatment options for locally advanced pancreatic cancer, comparing NALIRIFOX with PD-1 sequenti…
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating an albumin-bound formulation of docetaxel in patients with advanced pancreatic cancer; the study is currently not r…
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating Ivonescimab (AK112/SMT112) in combination with stereotactic body radiation therapy and chemotherapy for pancreatic …
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: IX001 TCR-T In the Treatment of Advanced Pancreatic Cancer and Colorectal Cancer Induced by KRAS Mutations [Phase 1]
A Phase 1 clinical trial evaluating IX001 TCR-T therapy for advanced pancreatic cancer and KRAS-mutant colorectal cancer is currently recrui…
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Multi-omics Model for Pancreatic Cancer Screening Using cfDNA
This entry notes an ongoing clinical trial funded by Fudan University to evaluate a multi-omics model using circulating-free DNA for pancrea…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical study evaluating Adebrelimab combined with decitabine, albumin-bound paclitaxel, and gemcitabine as first-line therapy …
-
CLINICAL_TRIALS research · 2024-06-27Clinical Trial Update: Evaluate the Safety and Efficacy of BGT007H Cell Therapy in Patients With Relapsed/Refractory Pancreatic Cancer [NA]
A recruiting clinical trial is evaluating the safety and efficacy of the BGT007H cell therapy for patients with relapsed or refractory pancr…